Piperine, an Alkaloid Component of Nigerian Propolis, Improves the Glomerular Filtration Rate (GFR) and other Markers of Renal Health in Nephropathic Diabetic Rats
Abstract
Materials and Methods: Male Wistar rats were induced with diabetes using streptozotocin and subsequently developed nephropathy. The rats were divided into 5 groups: a healthy control group, a diabetic (untreated) control group, a piperinetreated group, a metformin-treated group, and a group receiving a combination of piperine and metformin. Each treatment group received its respective interventions for 6 weeks. Renal function was assessed by measuring glomerular filtration rate (GFR) using inulin clearance tests. Biochemical markers of kidney injury and inflammation were also analyzed.
Results: The results indicate that the combination of piperine and metformin was more effective at improving renal function in nephropathic diabetic rats compared to either treatment alone. The rats receiving the combined therapy exhibited significantly higher GFR values and reduced markers of kidney injury and inflammation. In contrast, the individual treatments with piperine or metformin alone produced only moderate improvements. The untreated diabetic control group had substantially impaired renal function compared to all the treatment groups, while the healthy control group maintained normal GFR levels.
Conclusion: The synergistic effects of piperine from Nigerian propolis and metformin significantly enhanced GFR in nephropathic diabetic rats compared to either treatment alone. The combination therapy appears to offer a more effective approach for improving renal function in diabetic nephropathy.
Keywords
Full Text:
PDFReferences
Forbes JM, Cooper M E. Mechanisms of diabetic complications. Physiol Rev 2013;93:137-88.
Chaudhary N, Tyagi N. Diabetes mellitus: an overview. J Res Dev Pharm Life Sci 2018;7:3030-3.
Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998;352:213-9.
Sharma DK, Bhattacharya P, Kalia K, Tiwari V. Diabetic nephropathy: new insights into established therapeutic paradigms and novel molecular targets. Diab Res Clin Prac 2017;128:91-108.
Perneger T, Brancati, FL, Whelton, PK, Klag MJ. End-stage renal disease attributable to diabetes mellitus. Ann Internal Med 1994:121:912-8.
Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diab 2015;6:1246-58.
Zamlauski-Tucker MJ, Springate JE, Liew JBV, Noble B, Feld L. Glomerular function in spontaneously diabetic rats. Exp Biol Med 1992;199:59-64.
López-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol 2015;4:57-73.
Chavda VP, Chaudhari AZ, Teli D, Balar PC, Vora LK. Propolis and their active constituents for chronic diseases. Biomedicines 2023;11:259.
Marcucci MC. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 1995;26:83-99.
Miguel MG, Antunes MDC. Is propolis safe as an alternative medicine? J Pharm Bioallied Sci 2011:3:479-95.
Hossain R, Quispe C, Khan RA, Saikat ASM, Ray P, Ongalbek D, et al. Propolis: an update on its chemistry and pharmacological applications. Chin Med 2022;17:100.
Al-Hariri M. Immune’s-boosting agent: immunomodulation potentials of propolis. J Fam Comm Med 2019;26:57-60.
Yang H, Dong Y, Du H, Shi H, Peng Y, Li X. Antioxidant compounds from propolis collected in Anhui, China. Molecules 2011;16:3444-55.
Xu W, Han L, Yuan Y, Deng Z, Zheng L, Li H. The antioxidant and anti-inflammatory effects of flavonoids from propolis via Nrf2 and NF-κB pathways. Foods 2022;11:2439.
Waldner-Tomic N, Vanni R, Belibasakis GN, Thurnheer T, Attin T, Schmidlin PR. The in vitro antimicrobial efficacy of propolis against four oral pathogens: a review. Dent J 2014;2:85-97.
Mustafa IO. Nigerian propolis improves blood glucose, glycated hemoglobin A1C, very low-density lipoprotein, and high-density lipoprotein levels in rat models of diabetes. J Int Ethnopharm 2016;5:233–8.
Syaifie PH, Harisna AH, Nasution MAF, Arda AG, Nugroho D, Jauhar MM. Computational study of asian propolis compounds as potential anti-type 2 diabetes mellitus agents by using inverse virtual screening with the DIA-DB web server, tanimoto similarity analysis, and molecular dynamic simulation. Molecules 2022;27:3972.
Silva-Carvalho R, Baltazar F, Aguiar CA. Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development. Evid Compl Alt Med 2015;2015:1-29.
Falcão SI, Lopes MTDR, Vilas Boas M. A first approach to the chemical composition and antioxidant potential of Guinea- Bissau propolis. Nat Prod Comm 2019;14. doi: 10.1177/ 1934578X19844138.
Bankova V. Chemical diversity of propolis and the problem of standardization. J Ethnopharm 2005;100:114-7.
Bankova V, Trusheva B, Popova M. Propolis extraction methods: a review. J Apicul Res 2021;60:734-43.
Aminimoghadamfarouj N, Nematollahi A. Propolis diterpenes as a remarkable bio-source for drug discovery development: a review. Int J Mol Sci 2017;18:1290.
Gardana C, Scaglianti M, Pietta P, Simonetti P. Analysis of the polyphenolic fraction of propolis from different sources by liquid chromatography–tandem mass spectrometry. J Pharm Biomed Analysis 2007;45:390-9.
Mgbeahuruike E, Yrjönen T, Vuorela H, Holm Y. Bioactive compounds from medicinal plants: focus on Piper species. S Afr J Botany 2017;112:54-69.
Salehi B, Zakaria ZA, Gyawali R, Ibrahim SA, Rajković J, Shinwari ZK. Piper species: a comprehensive review on their phytochemistry, biological activities and applications. Molecules 2019;24:1364.
Sriwiriyajan S, Tedasen A, Lailerd N, Boonyaphiphat P, Nitiruangjarat A, Deng Y, et al. Anticancer and cancer prevention effects of piperine-free piper nigrum extract on N-nitrosomethylurea-Induced Mammary Tumorigenesis in rats. Cancer Prev Res 2016;9:74-82.
Lloyd M, Demayo CG, Meve U, Liede Schumann S, Alejandro GJD. Molecular confirmation, constituents and cytotoxicity evaluation of two medicinal Piper species used by the Manobo tribe of Agusan del Sur, Philippines. Phytochem Letters 2020; 36:24-31.
Bhambhani S, Kondhare KR, Giri AP. Diversity in chemical structures and biological properties of plant alkaloids. Molecules 2021;26:3374.
Ahmad N, Fazal H, Abbasi BH, Farooq S, Ali M, Khan MA. Biological role of Piper nigrum L. (black pepper): a review. Asian Pac J Trop Biomed 2012;2:S1945-53.
Njeri LK, Njagi E. Anti-diabetic activity in mice of Piper capence used traditionally in the management of diabetes mellitus in Kenya. J Diab Metab 2017;8. doi: 10.4172/2155-6156.1000737.
Sedor JR, Kang HM, Hostetter TH, Suszták K. Molecular mechanisms of diabetic kidney disease. J Clin Invest 2014; 124:2333-40.
Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. J Diab Invest 2015;6:242-6.
Alicic RZ, Rooney MN, Tuttle KR. Diabetic kidney disease. Clin J Amer Soc Nephrol 2017;12:2032-45.
Jain K, Mottl AK. Comprehensive care for people with diabetic kidney disease. Diab Spectr 2015;28:187-92.
Bispo JAM, Vieira EEDS, Silveira L, Fernandes AB. Errata: correlating the amount of urea, creatinine, and glucose in urine from patients with diabetes mellitus and hypertension with the risk of developing renal lesions by means of Raman spectroscopy and principal component analysis. J Biomed Optics 2016;21:59801.
Wu T, Ding L, Andoh V, Zhang J, Chen L. The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update. Life 2023;13:539.
Vieira EEDS, Silveira L, Carvalho HC, Bispo JAM, Fernandes FB, Fernandes AB. Biochemical analysis of urine samples from diabetic and hypertensive patients without renal dysfunction using spectrophotometry and raman spectroscopy techniques aiming classification and diagnosis. Bioengineering 2022;9:500.
Mirić D, Kisić B, Puhalo-Sladoje D, Mirić B, Rašić D, Dragojević I, et al. Relationship between ACR and other determinants of microalbuminuria in T2DM patients. Praxis Medica 2020;49:1-6.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.